reference/12110869

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12110869

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	507
issn	0304-4165
issueIdentifier	3
pageRange	498-507
publicationName	Biochimica et Biophysica Acta (BBA) - General Subjects
startingPage	498
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dec9c600796dff67ee7f3ea310fc2bae http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fb73fdf6a0c7db43d711096a3c8528f9 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_58fa5cc45c61f0e77f2972e4641a60a0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_49672f39c60f6d199f4af9ae3f136d96
bibliographicCitation	Xia M, Erickson A, Yi X, Moreau R. Mapping the response of human fibroblast growth factor 21 (FGF21) promoter to serum availability and lipoic acid in HepG2 hepatoma cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 2016 Mar;1860(3):498–507. doi: 10.1016/j.bbagen.2015.12.004.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc9feddcfe2fcce5e04c9854fbf3b6b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9303-0759 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25b8381e9f6ad06ff4a46b45a13cb333 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac88892d3b6257eabddbadb3d8d09419
date	201603
identifier	https://pubmed.ncbi.nlm.nih.gov/26691139 https://doi.org/10.1016/j.bbagen.2015.12.004
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/47937 https://portal.issn.org/resource/ISSN/0304-4165
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Mapping the response of human fibroblast growth factor 21 (FGF21) promoter to serum availability and lipoic acid in HepG2 hepatoma cells
discusses	http://id.nlm.nih.gov/mesh/M0064201 http://id.nlm.nih.gov/mesh/M0008437 http://id.nlm.nih.gov/mesh/M0371510 http://id.nlm.nih.gov/mesh/M0010429 http://id.nlm.nih.gov/mesh/M0012565
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D044967Q000502 http://id.nlm.nih.gov/mesh/D005346Q000235 http://id.nlm.nih.gov/mesh/D008063Q000494 http://id.nlm.nih.gov/mesh/D011401
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008063Q000031 http://id.nlm.nih.gov/mesh/D006657Q000378 http://id.nlm.nih.gov/mesh/D056945
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fd4f4a57669e0f4c45eb5cc883ad7e4e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6112 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44415057 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2019 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131954673 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5694 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78357827 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID457193 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_84b558f4432e9ad517f6e85756e9205a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6713178 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9297 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71306720 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549144 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21854522

Total number of triples: 56.